Screening of new KL-6-associated mucins useful in clinical diagnosis of interstitial pneumonitis
Screening of new KL-6-associated mucins useful in clinical diagnosis of interstitial pneumonitis
批准号:
06670618
负责人:
KOHNO Nobuoki
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Screening of murine monoclonal antibodies which react with novel antigenic deternlinants on KL-6 molecules was performed last year.EK-7 monoclonal antibody was finally selected for the purpose this year.EK-7 antibody was IgM and reacted with an antigenic determinant different from the determinant recognized with KL-6 antibody. The antigenic determinant was peptide portion of KL-6 molecules.The PEP-76 molecule in serum which was detected by a sandwich type of enzyme immunoasssay using EK-7 antibody as a catcher and KL-6 antibody as a tracer was designated as PEP-76. The method using 96-well EIA plates was similar to that for the measurement of KL-6.Study population was 51 healthy individuals, 13 patients with idiopathic interstitial pneumonia and 12 patients with sarcoidosis.PEP-76 level was 0.9 (0.9-3.9) U/ml [median (range)] in healthy individuals, 54 (0.9-580) U/ml in idiopathic interstitial pneumonia, and 1 (0.9-13) U/ml in sarcoidosis. Both the levels in idiopathic interstitial pneumonia and sarcoidosis were statistically higher than that in healthy individuals. when the cut-off level of PEP-76 was determined at 2.7 U/ml from the distribution of the levels of healthy individuals, the positive rate was 92% in idiopathic interstitial pneumonia and 33% in sarcoidosis. The sensitivity of PEP-76 was higher than that of KL-6 in same sera from patients with interstitial pneumonitis.These observations indicate that PEP-76 is a novel serum marker for the diagnosis of interstitial pneumonitis.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
横山 彰仁、他: "間質性肺炎における血清トロンボモジュリンの検討" 日本胸部疾患学会雑誌. 32. 951-955 (1994)
Akihito Yokoyama 等:“间质性肺炎中血清血栓调节蛋白的检查”日本胸科疾病学会杂志 32. 951-955 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yokoyama A,et al.: "Circulating interleukin-6 levels in patients with bronchial asthma" Am J Respir Crit Care Med. 151. 1354-1358 (1995)
Yokoyama A 等人:“支气管哮喘患者的循环白细胞介素 6 水平”Am J Respir Crit Care Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yokoyama A,Kohno N,Fujino S,Hamada H,Inoue Y,Fujioka S,Ishida S,Hiwada K.: "Circulating interleukin-6 levels in patients with bronchial asthma" Am J Respir Crit Care Med. 151. 1354-1358 (1995)
Yokoyama A、Kohno N、Fujino S、Hamada H、Inoue Y、Fujioka S、Ishida S、Hiwada K.:“支气管哮喘患者的循环白细胞介素 6 水平”Am J Respir Crit Care Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yokoyama A,et al.: "Evaluation of soluble interleukin-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases" Clin Exp Immunol. 100. 325-329 (1995)
Yokoyama A 等人:“间质性肺病患者血清和上皮内衬液中可溶性白细胞介素 6 受体浓度的评估”Clin Exp Immunol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujioka S,et al.: "Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S" Jpn J Cancer Res. 86. 368-373 (1995)
Fujioka S 等人:“Ubenimex 激活乳腺癌细胞系 YMB-S 的 E-钙粘蛋白介导的粘附”Jpn J Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Anti KL-6 antibody enhances the effects of molecular targeted drug
-
批准号:23659433
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:KOHNO Nobuoki
-
依托单位:
Comparative studies of a clinical features and genomic analysis in patients with interstitial lung disease and drug induced lung injury
-
批准号:19390224
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:KOHNO Nobuoki
-
依托单位:
The Study on KL-6 as Morbidity Ornamentation Factor and Prognosis Factor of Idiopathic Interstitial Pneumonia.
-
批准号:14370197
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2002
-
负责人:KOHNO Nobuoki
-
依托单位:
The Establishment of KL-6 Associated New Serum Markers Using High Sensitive Electrochemiluminescence Immunoassay.
-
批准号:13557051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2001
-
负责人:KOHNO Nobuoki
-
依托单位:
DEVELOPMENT OF A LUNG CANCER TREATMENT USING ANTI-KL-6/MUC1 MULTI-MONOCLONAL ANTIBODIES
-
批准号:10670548
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:KOHNO Nobuoki
-
依托单位:
Clinical Significance of Anti-MUC1 Natural Autoantibody in Sera from Patients with Lung Cancer
-
批准号:08670665
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:KOHNO Nobuoki
-
依托单位:
Differentiation Induction of a Cell Line with a Monoclonal Antibody
-
批准号:03807040
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1991
-
负责人:KOHNO Nobuoki
-
依托单位: